Endometriosis Surgical Excision Treatments For Fertility Preservation Announced

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Lotus Endometriosis Institute announces the availability of robotic excision surgery as a fertility-preserving treatment for endometriosis.

-- As announced by Lotus Endometriosis Institute, open slots are available for robotic excision surgery as the center advances its fertility-preserving approach to endometriosis treatment. The institute notably positions robotic excision as a strong surgical option for women who want endometriosis removed while protecting their reproductive future.

For more information, visit: https://lotusendo.com/services/surgery-and-advanced-excision

Fertility preservation is an important topic for those facing endometriosis, with the center linking the disease to a substantial impact on reproductive organs and planning. Such patients can potentially take solace in Lotus Endometriosis Institute’s recent news, then - with the team pointing to its own robotic-assisted approach as a safe and effective method.

The technique frequently comes into play for cases involving deep infiltrating disease, with the institute indicating that excision surgery, in general, can improve fertility outcomes. Such results stem largely from the technology used. For example, the team highlights the DaVinci robotic system as an advanced form of minimally invasive surgery that gives surgeons wristed instruments capable of movements more precise than the human hand.

High-definition 3-D optics magnify anatomy up to 12 to 15 times, adds the institute, allowing even small, flat lesions to be identified and removed while sparing healthy tissue near the ovaries and fallopian tubes.

Such levels of precision separate excision from ablation, the two dominant surgical philosophies in endometriosis care. Lotus Endometriosis Institute refers to ablation as a technique that burns or lasers visible lesions while often leaving disease beneath the surface. Excision, meanwhile, is described as the art of removing endometriosis at its roots using cold scissors and calculated cautery, an approach associated with lower recurrence, improved organ protection, and fertility preservation support for patients planning pregnancy.

Their spokesperson explains: “If you’re trying to avoid organ removal, we can help map likely disease sites, clarify your priorities for pain relief, function, and fertility, and outline what organ-preserving excision could realistically look like in your specific case. We can then build a surgical plan around that.”

Under the leadership of Dr. Steven Vasilev, more women have access to an approach that frequently delivers promising results in straightforward and complex cases alike. Women considering fertility-preserving options for endometriosis are urged to schedule a virtual consultation to discuss whether robotic excision aligns with their treatment and family-planning goals.

Interested parties can find further details about the institute's mission and approach to integrative care at: https://lotusendo.com

Contact Info:
Name: Dr. Steven Vasilev
Email: Send Email
Organization: Lotus Endometriosis Institute
Address: 154 Traffic Way, Arroyo Grande, CA 93420, United States
Website: https://lotusendo.com

Source: PressCable

Release ID: 89205906

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.53
-2.90 (-1.11%)
AAPL  340.97
+4.33 (1.29%)
AMD  594.24
-13.86 (-2.28%)
BAC  54.58
+0.26 (0.48%)
GOOG  348.97
+1.11 (0.32%)
META  742.96
+24.29 (3.38%)
MSFT  541.15
+6.08 (1.14%)
NVDA  226.32
-2.96 (-1.29%)
ORCL  137.39
-4.01 (-2.84%)
TSLA  378.03
-4.67 (-1.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.